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Abstract. 
Carcinogenicity prediction is an important process that can be performed to cut down 
experimental costs and save animal lives. The current reliability of the results is however disputed. 
Here, a blind exercise in carcinogenicity category assessment is performed using augmented top 
priority fragment classification. The procedure analyses the applicability domain of the dataset, 
allocates in clusters the compounds using a leading molecular fragment, and a similarity measure. 
The exercise is applied to three compound datasets derived from the Lois Gold Carcinogenic 
Database. The results, showing good agreement with experimental data, are compared with 
published ones. A final discussion on our viewpoint on the possibilities that the carcinogenicity 
modelling of chemical compounds offers is presented. 
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1. INTRODUCTION 
Carcinogenicity in humans is the most alarming characteristic of chemicals for citizens and it is 
frequently cited as the biggest barrier to the commercialization of chemicals.(Benigni, 2005) 
Regulatory agencies are deeply involved in assessing compound safety and, in this regard, are 
making any sensible effort to control that the cancer risk is minimized; in this perspective, several 
controls are required to companies before a new compound can be introduced into the 
market.(OECD, 2002; US EPA, 2005) Considering the cost of the experimental tests and the ethical 
aspects of the animal tests, the possibility to predict the carcinogenicity of compounds is appealing. 
However, the mechanisms that operate in cancer development are numerous and not yet fully 
understood.(Benigni and Bossa, 2011; Cimino, 2006) In addition, the variability of the chemical 
structure is so wide that sometimes it is difficult to locate the moiety that is responsible for the 
activity. To complicate the problem, it should be mentioned that, although the presence of a 
particular moiety can be defined as the responsible for a harmful action, it is much more difficult to 
determine the molecular part that can partly or fully prevent the cancer development.(Maurici et al., 
2005) 
Chemicals’ carcinogenicity prediction has been discussed and studied for long time.(Guyton et 
al., 2009; Benigni et al., 2007)  Several reports present both quantitative and qualitative models 
with results at variable level.(Fjodorova et al., 2010; Zhong et al., 2013; Patlewicz et al. 2003; 
Helguera et al., 2005a; Helguera et al., 2005b; Helguera et al., 2006; Passerini, 2003)  Referring to a 
recent review by Benigni and Bossa (Benigni and Bossa, 2011) it appears clear that the modelling 
of carcinogenicity is difficult because the problem is complex and not well understood. Experiments 
are often scarce in number and scope, thus limiting a consistent rationalization. Benigni and Bossa 
(2011) clearly show that: a) the characterization of experimental mechanisms of action of chemicals 
in cancer promotion is inadequate; b) the relation of structure characteristics with cancer Mode of 
Action (MOA) is puzzling; c) the current models, though using approximate theoretical principles, 
are comparable to experimental determinations. The last sentence does not imply that the problem 
of predicting compound carcinogenicity is solved, it only highlights that the still limited models 
available give predictions that are correct at the same level as the experimental determinations. As 
already pointed in the previous lines, the understanding of cancer development is still limited and, 
as a consequence, the developed models still need improvements. 
Some recent studies use the common procedure to classify compounds into carcinogens and non 
carcinogens.(Fjodorova et al., 2010; Zhong et al., 2013) The models therein developed follow the 
conventional statistical approach: 1) choosing a set of experimental results; 2) calculating several 
molecular descriptors; 3) dividing the experimental data into a training and a test set; 4) statistically 
validating the models. The results are very similar, as expected, and their discussion points to the 
model predictability and to the search for a molecular rationalization of the model descriptors. 
In this paper we pursue a different goal: we test the possibility to reach a result comparable with 
that present in the literature using a classification based exclusively on the molecular structure. In 
our study we do not use the experimental results to drive the model development; in contrast, we 
will only check a posteriori if our classification can be used to predict carcinogenicity with the same 
confidence. In addition, we will briefly discuss the current reliability of our prediction. 
Augmented Top Priority Fragments were recently described.(Casalegno and Sello, 2013) They 
are the result of the combination of two different procedures: the first groups compounds using a 
mixture of molecular similarity and atomic group composition;(Casalegno et al., 2008) the second 
analyses and validates the groups using functional groups calculated by means of the electronic 
energy.(Sello, 1992) The application of this procedure to a set of compounds comprises the 
following steps: 1) a check of the applicability domain to identify the outliers in the chemical space 
associated with a set of structural descriptors (i.e. molecular fragments); 2) the exclusion of all the 
molecules that cannot be inserted in a subset of at least four components; 3) the assignment of the 
remaining compounds to one or more sets; 4) the selection of the most significant set for each 
compound. No use of the biological activity is required to perform this procedure. 
The aim of the current study is to: a) present the results, that can be used in many applications, in 
the context of carcinogenicity prediction; b) discuss the results in comparison with recently 
published ones; c) eventually, assess the feasibility of the use of models for carcinogenicity 
prediction. 
 
2. MATERIALS AND METHODS 
2.1. Chemical Data 
In this study, we considered three datasets. The first set (hereafter called SET1) derived from the 
Carcinogenic Potency Database (CPDBAS) and was used by Zhong et al. (2013) It contains 852 
non congeneric compounds with well-defined chemical structures, including 449 carcinogens and 
403 non carcinogens. The second set  (hereafter called SET2) contains 802 chemicals, including 
420 carcinogens and 382 non carcinogens, which were extracted from the Distributed Structure-
Searchable Toxicity (DSSTox) Public Database Network 
(http://www.epa.gov/ncct/dsstox/sdf_cpdbas.html)(CPDBAS) derived from the Lois Gold 
Carcinogenic Database (http://potency.berkeley.edu/) (CPDB); the set was used by Fiodorova et 
al.(2010) The third set  (hereafter called SET3) contains 1118 compounds extracted from the 
Istituto Superiore della Sanità (ISS) database (ISSCANv3a),(Benigni et al., 2008) including 574 
carcinogens, 354 non carcinogens and 190 undetermined compounds. It should be noted that the 
three data sets share several molecules (90% overlap between SET1 and SET2; 83% overlap 
between SET2 and SET3). The carcinogenicity is referred to studies on rats. The total number of 
unique compounds is 1359 (of which 887 were analysed, see Table 1). The use of three overlapping 
datasets allows to highlight the differences that can originate by the application of the model, thus 
permitting the result comparison and the model study. We stress that no experimental data was used 
to train our model; as a consequence, all the three sets should be considered external test sets. In 
contrast with more conventional training/test methodology, our model assigns compounds to 
subsets ignoring any kind of activity information. Hence, carcinogenicity data are only used with 
the purpose to test the model predictive capabilities. 
 
2.2. Method Overview 
The method used in the current study has been already described.(Casalegno and Sello, 2013) As 
a consequence, we are not going to provide here an exhaustive description; however, we would like 
to provide a qualitative view of its fundamentals. The procedure is based on the application of two 
methods; the first generates some clusters that contains a selection of molecules;(Casalegno et al., 
2011) the second extends and validates the clusters.(Sello, 1992) Cluster generation is based on the 
mapping of a fragment-based representation onto a cluster-based one.(Casalegno et al., 2008) Using 
structural fragments (SFs) we generate a chemical space that is used to build the clusters. As in our 
previous works, we adopted here the Atomic Centered Units (ACUs) as SFs. Clusters are groups of 
compounds sharing a common SF. Thus, each compound belong to as many clusters as the number 
of its constituent fragments. This permits the description of a molecule by means of membership in 
clusters (also referred to as groups); at the same time, a function called affinity is used to determine 
cluster memberships. At the end of the calculation, groups containing some compounds are formed; 
a compound can be present in more than one group. Compounds not belonging to any group are 
collected in a special group, called the outlier group. 
In this method the fragments do not have any special reactivity meaning; so, to complete the 
molecule description we use a second method, developed to define and locate functional groups. 
The method uses the electronic description of atoms to define their importance and to collect 
interacting atoms into functional groups (FGs, hereafter).(Sello, 1992)  
As described previously (Casalegno and Sello, 2013), the two above strategies can be combined 
with the aim at grouping compounds sharing similar structures and activity. To this end, the 
representation provided by the SFs is mapped onto that based on the FGs. This process comprises 
four sequential steps, namely: 1) SF-FG mapping, 2) cluster merging, 3) cluster selection, and 4) 
cluster splitting. For better clarity, hereafter, we quickly resume these steps. SF-FG mapping is 
carried out by cross checking the atoms that belong to the SF and to the FG: all the SF atoms should 
belong to one FG, otherwise the molecule is removed from the cluster. This process aims at 
establishing a one-to-one correspondence between SFs and FGs, for each molecule in a specific 
cluster. Cluster merging is performed to merge SFs that are closely similar, and reduce the total 
number of SFs. When two SFs are merged, also the molecules assigned to the corresponding 
clusters become part of the same cluster. Cluster selection is then performed to select for each 
compound belonging to many clusters, only the cluster associated with the highest affinity value. It 
should be noted that the affinity values were obtained during the initial SF-based clustering process. 
Finally, we inspect each cluster, looking for molecules characterized by FGs of different lengths. 
Since these FGs may show different reactivities, these molecules are assigned to different sub-
clusters within the main cluster (i.e., cluster splitting). 
In the following we will often use the terms selectivity, specificity and accuracy with reference 
to statistical significance of the results. These are defined as:  
Selectivity = TP / (TP + FN),  
Specificity = TN / (TN + FP)  
Accuracy = (TP+TN)/(TP+FP+TN+FN), 
where TP, FP, TN, and FN, refer to the number of True Positives, False Positives, True 
Negatives, and False Negatives, respectively. The total number of experimental carcinogenic 
compounds is TP + FN, and of non-carcinogenic compounds is TN + FP. 
 
3. RESULTS  
Carcinogenicity prediction is an important target because it can reduce both costs and animal 
experiments. The use of either QSAR or SAR is of great importance because the modelling of 
scientific instances not only helps the solution of a problem but also requires its rationalization. It is 
clear enough that we cannot currently apply QSAR to carcinogenicity prediction with confidence 
and that the assessment of carcinogenicity categories can be nevertheless an important 
achievement.(Benigni and Bossa, 2011) However, even this limited objective is not completely 
established. The question is: can we accept the theoretical categories and use them with confidence? 
In the following we present the results of the application of our model to the three selected datasets 
and in the Discussion section we will try to answer the question. As already mentioned the three 
datasets that we used in our analysis are derived from the same source: the Lois Gold Carcinogenic 
Database (CPDB). As a consequence, there is some overlap between the sets; more exactly, 90% 
overlap between SET1 and SET2; 83% overlap between SET2 and SET3, considering the smallest 
set. We can thus expect similar results in the model application. However, it should be noted that 
our model generates classes using all the compounds of a set; this has the consequence that classes 
can be different even using sets with similar member composition. Another difference between 
SET3 and SET1 and SET2 concerns the compound activity; because both SET1 and SET2 were 
selected to train Zhong et al. (2013) and Fiodorova et al. (2010) models using the compound 
activity they cannot include in the analysis compounds whose activity is missing. By contrast, our 
model has not such limitation and can be also applied to SET3 that contains compounds whose 
activity has not been measured. 
 
3.1. Applicability Domain 
 
The first outcome of the application of the model is the selection of those compounds that are 
outside the applicability domain. These compounds exclusively contain SFs that either are singly 
represented or are found in too many molecules (thus being useless for the selection procedure). 
The applicability domain is strictly dependent on the set composition; this fact is evident looking at 
the detected outliers. The number of outliers is 85, 88, and 96, for SET1, SET2, and SET3, 
respectively. Even in the presence of an important set overlap the outlier overlap is nevertheless 
quite limited: 33 common compounds between SET1 and SET2, 54 common compounds between 
SET1 and SET3, 27 common compounds between SET2 and SET3. This result is explained by the 
rigid rule used by the procedure to select the outliers that asks for a complete uniqueness of the 
compound. It is thus sufficient that two structure share a common fragment to create a group. 
Some examples of outliers are reported in Figure 1. 
 
Figure 1. Examples of outliers detected in SET1, SET2 and SET3. 
Table 1. Dataset composition 
Dataset Compounds Positive Negative Outliers Rare Analysed SF 
SET1 852 449 403 85 151 616 72 
SET2 802 421 381 88 187 527 58 
SET3 1118 574
a
 354 96 213 809 74 
a
 In SET3 there are 190 compounds whose activity has not been experimentally determined 
 
In these examples it easy to see the presence of very small and simple compounds (SET1-2, 
SET1-132, SET2-30, SET3-25), of uncommon compounds (SET2-93, SET3-184), and of 
compounds containing only ordinary and unusual SFs (SET1-42, SET2-91, SET3-85). 
 
Figure 2. Examples of compounds excluded from SET1, SET2, and SET3, because members of too 
small subsets. 
 
The consequence of the formation of very small groups is considered by the successive group 
formation procedure. In fact, groups formed by less than four molecules are not considered. This 
generates a second subset (for each main set) of compounds that are not outliers but are not 
considered significant in the analysis of the compound activity. These subgroups contain 151 
compounds for SET1, 187 compounds for SET2, 213 compounds for SET3. The total number of 
excluded molecules is thus 236, 275, and 309, for SET1, SET2, and SET3, respectively; the 
analysed compounds are therefore 616, 527, and 809. In addition, in SET3 there are 125 compounds 
that have not an assigned experimental activity (Table 1). Some examples of excluded compounds 
are reported in Figure 2. In this case, the eliminated compounds usually contain some unusual SFs 
in a complex structure. 
At the end of this section a comment is necessary. It is sufficient the preliminary analysis 
performed by our model to highlight that the three datasets cannot be used without considering their 
composition. The applicability domain strongly influences the reliability of the results; the use in a 
model of compounds that are not well inside the domain should be considered with care, in 
particular when the dataset is highly varied. There is sometimes a problem with the definition of the 
applicability domain; in fact, using continuous variables as descriptors the domain can be easily 
defined by the variable ranges. In contrast, using structural descriptors the domain is defined by the 
substructure chemical space. In this case, the domain definition is not straightforward because it 
depends on the current interpretation of the chemical space. In our model two attributes are 
checked: the presence of the molecule fragments inside the space and the possibility of assigning 
the molecule to a group of similar compounds. 
 
3.2. Group Activity Assessment 
 
Our procedure divides compounds into subsets using a reference SF and a variable called affinity 
that measures the similarity of a compound to the other group components. The number of the 
subsets depends on two principal factors: the number of compounds and the variance of the set. All 
the examined datasets generate subsets containing less than 10 members on average, even after the 
exclusion of outliers and rare compounds. Obviously, there are subsets with more members (20-50) 
and subsets with less members (4, that is the minimum to have a subset). In this situation it is clear 
that the subsets have also a different reliability. It should be also considered that the same SF can 
generate more than one subgroup because the affinity of the compounds can function as an 
additional distinctive feature.  
As mentioned the subsets are formed without taking into account the activity data. When the 
division is terminated we assign to each subset a reference activity based on the most frequent 
activity in the subset; in case of equal activity distribution the positive attribute is assigned (i.e. we 
privileged the false positive result). To help understanding this point we can consider a subset 
containing 10 members; if more than 4 members (i.e. between 5 and 10) are active than the subset is 
defined active. As reported in Table 2, it is now possible to calculate the usual variables, accuracy, 
specificity, and selectivity, in order to verify the reliability of the predicted activities. Of course, the 
contribution of each subset to the total variables is weighted against the subset dimension. 
Concerning the accuracy, i.e. the overall correct prediction, the result is very similar near the 75% 
for all the sets. This was expected because the three sets are overlapping; however, the presence in 
SET3 of a consistent number of undetermined compounds could have implied a different result. 
The result is different when we examine the selectivity and the specificity. In fact, whilst SET1 
and SET2 show similar values, SET3 has a high selectivity and a low specificity. This outcome can 
be explained by two factors: the above mentioned choice towards false positive assignments and the 
presence of the undetermined compounds that allows the formation of sets containing some 
compounds that do not contribute to the activity determination. In addition, the ratio between active 
and inactive compounds is greater in SET3. 
 
Table 2. Significant statistical variables concerning the dataset analysis. 
Dataset Positive Negative FP FN 
Total 
errors 
Accuracy Selectivity Specificity 
SET1 325 291 81 61 142 76.9 81.2 72.2 
SET2 276 251 77 58 135 74.4 79.0 69.3 
SET3 405
a
 279 144 47 191 72.1 88.4 48.4 
a
 In SET3 there are 125 compounds whose activity has not been experimentally determined 
 
 3.3. Subset Analysis 
The datasets used in the analysis contain compounds with very different structures. As a 
consequence, the identification of the moiety responsible for the activity is not always 
straightforward. Nevertheless, in the following we will report the main known group located by the 
procedure. 
 
3.3.1. Nitro furans 
This moiety (Figure 3) is present in all the datasets. It is mainly found in carcinogenic 
compounds; nitro aromatic moieties are considered structure alerts by the Toxtree 
program.(Toxtree) Looking at the subsets formed by the procedure we observe that: 
In SET1 there is a subset containing 19 nitro furan derivatives, 18 of them are carcinogenic; the 
only exception is reported in Figure 4a. In addition compound SET1-692  is considered an outlier 
and compound SET1-264 is not analyzed (figure 4b). A second subset contains 4 more nitro furans 
that are all carcinogenic. Three other nitro furans (SET1-136, SET1-187 and SET1-196) are 
inserted in different subsets, because they also contain other moieties. 
 
Figure 3. Nitro furan moiety. 
 Figure 4. a) SET1-691 is a non carcinogenic compound. b) SET1-692 is an outlier and SET1-
264 is not analyzed because its affinity is too low. 
 
In SET2 there is a subset containing 16 compounds, all of them are carcinogenic. A second 
subset contains 6 compounds, 5 of them are also nitro furans. In the subset there is also the 
compound shown in Figure 5, that is not toxic; however, Toxtree (Toxtree) classifies the compound 
as carcinogenic. Three nitro furans cannot be inserted in any subset and are not classified. Finally, 
three more compounds are classified in different subsets. 
 
 SET2-338 
Figure 5. SET2-338 is a non carcinogenic compound. 
 
In SET3 there is a subset containing 18 compounds, all of them are carcinogenic. A second 
subset contains 12 compounds, one is not toxic (the same present in SET1, Figure 4a); one 
compound is not a nitro furan (the same present in SET2, Figure 5). 
Nitro furans are thus recognized as highly toxic moieties and very often the procedure correctly 
classifies them. The few exceptions are easily detected when a different classification is possible; 
whilst the wrong predictions cannot be explained. 
 
3.3.2. N-nitroso compounds 
The N-NO moiety is another well known carcinogenic alert. In the datasets many compounds 
containing this group are present; thus we can expect that they will be divided into some subsets. 
In SET1 118 compounds contain the N-NO group. They are representative of several molecular 
structures, as evidenced by their distribution into six main subsets containing 51, 6, 7, 5, 13, and 8, 
compounds; the remaining 28 compounds are: 2 outliers, 8 not analyzed, 18 in other groups. The 
main subset (51 compounds) contains 43 active and 8 inactive compounds (all the inactive 
compounds are found active by the Toxtree program). Considering all the classified compounds we 
observe 74 actives and 16 inactives. The error percentage is thus 17.8, showing that even in this 
particularly well defined case the error number can be significant. The 10 unassigned compounds 
have either few atoms or quite special structure; three examples are shown in Figure 6. Finally, 11 
compounds of the 18 assigned to other groups have a correct activity assignment. 
 
Figure 6. Unassigned compounds of SET1. 
 
In SET2 104 compounds contain the N-NO group. They are distributed into five main subsets 
containing 45, 12, 5, 6, and 7, compounds; the remaining 29 compounds are: 2 outliers, 6 not 
analyzed, 21 in other groups. The main subset (45 compounds) contains 37 active and 8 inactive 
compounds. Considering all the classified compounds we observe 59 actives and 16 inactives. The 
error percentage is thus 21.3. 
In SET3 120 compounds contain the N-NO group. They are distributed into four main subsets 
containing 57, 12, 8, and 4, compounds; the remaining 39 compounds are: 2 outliers, 12 not 
analyzed, 25 in other groups. The main subset (57 compounds) contains 48 active, 8 inactive, and 1 
undetermined compounds. Considering all the classified compounds we observe 69 actives, 11 
inactives, and 1 undetermined. The error percentage is thus 13.8. 
The N-NO moiety is certainly a reliable structural alerts; however, its presence is not sufficient 
to predict compound carcinogenicity. It could be interesting to analyze if there is some clear 
structural reason that detoxifies the group presence. However, looking at the structures of the 11 
inactives present in SET3 (as an example, Figure 7) the reason for their lack of reactivity is not 
always clear; e.g., some can be considered water soluble (e.g. containing a carboxylic residue), 
others geometrically hindered. 
 Figure 7. Non carcinogenic compounds in SET3 containing the N-NO moiety. 
 
3.3.3. Nitro benzenes and alkyl halides 
Aromatic compounds containing a nitro group are commonly considered carcinogenic and the 
group is considered a structural alert. However, this is not always the case. Analyzing a subgroup of 
this class in SET1, containing 21 compounds, we found 9 actives and 12 inactives. The structures 
are reported in Figure 8a and 8b. A subgroup of SET2 contains 18 nitro benzenes, of which 7 are 
actives and 11 are inactives. Similarly, the 42 nitro derivatives found in a subgroup of SET3 were 
classified as actives (19), inactives (17), and undetermined (6). It is almost impossible to find any 
reason to discriminate between the two molecule categories. 
 Figure 8. a) Carcinogenic compounds containing the aromatic NO2 moiety. b) Non carcinogenic 
compounds containing the aromatic NO2 moiety. 
 
Also alkyl halides are commonly recognized as structural alerts; however, our analysis reveals 
that the percentage of compounds of this class that are classified non carcinogenic is not far from 
50. Six examples (3 active, upper, and 3 inactive, lower) are reported in Figure 9. 
 
 Figure 9. Examples of carcinogenic (upper) and non carcinogenic (lower) compounds 
containing the alkyl halide moiety. 
 
3.3.4. Primary aromatic amines (anilines) 
Another well known and deeply studied functional group whose presence is related to the 
carcinogenicity of chemical compounds is represented by anilines. Also in this case we selected one 
subgroup in each set to present the analysis result. In SET1 the subgroup contains 21 compounds 
with 13 actives and 8 inactives. In SET2 the subgroup contains 25 molecules with 17 actives and 8 
inactives. In SET3 the subgroup contains 22 compounds with 12 actives, 4 inactives, and 6 
undetermined. Again the reason of the different experimental results is not evident looking at the 
structures. Some examples are reported in Figure 10a (actives) and 10b (inactives). 
 Figure 10. a) Carcinogenic compounds containing the aromatic NH2 moiety. b) Non 
carcinogenic compounds containing the aromatic NH2 moiety. 
 
4. DISCUSSION 
Cancer is still one disease of great concern for the developed world population. Life style and 
genetic heritage are certainly important factors for cancer development; however, at least part of the 
current occurrences can be associated to chemical toxicity. It is thus important to assert the hazard 
of compounds before, during, and after production and commercialization. In this perspective the 
possibility of using theoretical models can be of high interest for both economic and ethical reasons; 
but it is important to assess the reliability level of the predictions to avoid excessive  expectation 
followed by rapid disappointment.(Benigni and Bossa, 2011) 
Cancer development is a complex and not well understood mechanism; its modelling is therefore 
not well settled yet. Consequently, QSAR models are still missing (excluding few examples with 
congeneric compound set)(Passerini, L., 2003; Benigni, 2003) and SAR models are only few. Since 
the seventies the notion of structural alerts is the main qualitative scheme to help in carcinogenicity 
prediction, giving suggestions on the compound toxicity.(Miller and Miller, 1977; Miller and 
Miller, 1981a; Miller and Miller, 1981b) Structural alerts introduce the idea of biological 
mechanisms driven by the presence of specific substructures; in addition, they can be used to divide 
compounds into classes. Their importance is well recognized by regulatory agencies that are 
currently asking for compound classification as a practical mean to assign compound toxicity. 
In their deep and comprehensive recent review Benigni and Bossa (2011) discuss the state of the 
art and the reliability of the cancer prediction through models, highlighting the role of structural 
alerts and the contribution of mechanistic studies. Here, the attention is pointed to the importance 
that small substructures can have in driving specific interactions with cell elements; undoubtedly, 
the use of structural alerts had a noteworthy success in biological activity prediction.(Ashby and 
Tennant, 1988; Benigni and Bossa, 2006) A theoretically different approach uses the hypothesis 
that sufficiently similar moieties should have similar biological actions; as a consequence, 
molecular similarity is used to find the common structural characteristics.(Willett, 2006) Also in 
this case the straightforward use of the model takes to the formation of compound classes, that are 
also more well defined than those formed using alerts. Comparing the two approaches we can see 
that, whilst in the first approach the presence of a small part of a molecule could be overestimated, 
in the second approach the similarity between two compounds can be found even neglecting the 
presence of exactly that small part that is fundamental for the biological action. In addition, neither 
approach is explicitly forming subsets. 
This work is a former attempt to demonstrate that compound carcinogenicity can be predicted by 
means of a fully blind analysis, with an accuracy comparable to that reached by models trained on 
experimental data. Our proposal focuses on the combination of the alert presence together with a 
significant molecular similarity. This way, the procedure is going to form subsets that implicitly 
comply with both requirements. The analysis of the applicability domain of the set is part of the 
procedure; the model analyses the set of compounds searching for outliers and for compounds that 
do not comply with the method rules. The identification of these compounds leads to their exclusion 
from the subsequent analysis. The procedure is also general and applicable to any molecular set, 
generating subsets that can be then used to assess any molecular property: It is the property that 
originates from the starting dataset that determines the application of the results. 
Two recent studies on carcinogenicity prediction (by Zhong et al., 2013; and by Fiodorova et al., 
2010) use very similar datasets to classify compounds: carcinogenic and non carcinogenic. Both 
models use a standard statistical approach where, through the activity information taken from the 
literature, the model is trained and optimized; then, one or more test sets are used for the validation 
step. The obtained result is sufficiently similar: high accuracy for the training sets (>80% and 
>90%) and good accuracy for the test sets (>70% and >65%). Also selectivity and specificity are 
notable, as can be appreciated looking at Table 3. The result interpretation is also discussed to some 
extent, mainly by Zhong et al., controlling the presence/absence of structural alerts, or of compound 
subgroups. 
 
Table 3. Significant statistical variables concerning the dataset SET1 and SET2 from literature 
data (Fjodorova et al., 2010; Zhong et al., 2013). 
Dataset Accuracy Selectivity Specificity 
Training SET1 82.3 n.a. n.a. 
Test SET1 72.0 72.4 71.3 
Training SET2 98.9 87.5 92.2 
Test SET2 65.2 70.7 68.3 
 
Our results on SET1 and SET2 were obtained without partitioning the full sets in training and 
test subsets. Nonetheless, a comparison with the results above referenced can be informative. The 
statistical significance of our results is comparable to that reported in Table 3 (accuracy: 76.9, 74.4; 
selectivity: 81.2, 79.0; specificity: 72.2, 69.3; for SET1 and SET2, respectively).  Some other 
benefits emerge from the application of our approach: 1) some compounds that are supposed to 
hinder the analysis are automatically excluded; 2) the reliability of the subgroups can be assessed 
from the number of their members; 3) the presence of possible structural alerts can be directly 
evidenced looking at the SF of the subgroup, or it can be verified checking the subgroup in a 
following action. 
The main achievement is however the possibility to find subgroups of inactive compounds. 
Because the inactivity is not determined by the presence/absence of alerts, it is always very difficult 
to search for inactive compounds. Our procedure groups together those compounds that are similar 
and that possess all the characteristics to be inactive. This result is possible even if the compounds 
contain an alert. This is a fundamental aspect in activity prediction: whilst the activity is triggered 
by the presence of a particular moiety, the lack of activity is always the result of the contribution of 
several different features. Even the concept of detoxifying groups is not sufficient, because it does 
not consider other compound attributes like, for example, molecular dimension or solubility. 
In the Result section the presence of special SF in some subgroups is presented. The unbiased 
formation of subgroups permits to easily uncover both expected and unexpected outcomes. For 
example, the well known toxicity of nitro furans is clear. In contrast, the presence of both nitro 
benzenes and alkyl halides, commonly considered toxic substructures, is questioned by our result.  
It is now the time to answer to our initial question: is it reasonable to assess compound 
carcinogenicity via in-silico models ? Since cancer represents a major social and economical issue, 
also in relation with the its financial and psychological impact, we believe we should positively 
answer to this question.   
Unfortunately, the availability of reliable experimental data and the understanding of the cancer 
mechanisms are still insufficient to guarantee a meaningful quantification of the risk. It remains the 
possibility of achieving a qualitative compound classification. If we consider the statistical 
significance of model application to test compounds (accuracy always greater than 70%), our 
answer to the initial question can be affirmative. At least, in the limited target of qualifying 
compounds as potentially carcinogenic we can accept the application of models. However, great 
attention should be paid to the result analysis; we still have to live in a significant uncertainty. 
Whilst the predicted toxicity of a compound can be often accepted, the prediction of the absence of 
toxicity is uncertain; we should carefully check all the facets of the prediction report before 
accepting the result. The applicability domain is fundamental; an accurate control of the relation 
between the structures in the dataset and the membership of the query compound should be done. It 
is sometimes inadequate to check the density of the domain and the position of the query; we should 
also check the presence/absence of special features in the target structure and/or in the dataset. In 
case of a classification, it is necessary to control the composition of each class and to give a 
reliability index to the class of concern.  
Eventually, if an uncertainty is still present, it is preferable to reject the prediction.  
 
5. CONCLUSIONS 
We presented this exercise with the aim at carefully testing the possibility of predicting 
carcinogenicity. In this perspective, we chose one of the most popular dataset (CPDB) as the source 
of three partitions for the exercise; we studied their applicability domains; we blindly applied a 
categorization procedure; we compared our result to two of the most recent examples. The final 
outcome does not fully support the implementation of theoretical models to solve the task. 
Nevertheless, we believe that the development of the modelling activity should be pursued with 
conviction because this rationalization effort helps in understanding the experimental data and in 
making clearer the reliability of compound classification. In the future we expect more exciting 
results from both the experimental and the theoretical sides. 
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